🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a prospective, multi-cohort, single-centre, phase II clinical...
Status
Unknown
Location
Multiple Locations
Start Date
2023-11-01
Trial ID
NCT06055166
This study was designed to explore the safety and efficacy of Bevacizumab c...
Status
Unknown
Location
The Second Affiliated Hospital of Shandong First Medical University
Start Date
2021-12-24
Trial ID
NCT05170594
Treatments Being Tested
Main research purpose: To evaluate the effectiveness of Fluzoparib combined...
Status
Completed
Location
Fudan University Shanghai Cancer Center
Start Date
2021-07-19
Trial ID
NCT04869488
This study is an open-label, single-arm, multicenter clinical study. 64 pat...
Status
Recruiting
Location
Breast Cancer, Peking University People's Hospital
Start Date
2022-10-01
Trial ID
NCT05576389
Treatments Being Tested
Ovarian cancer is one of the most fatal malignant tumors that threaten wome...
Status
Recruiting
Location
Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology
Start Date
2022-01-14
Trial ID
NCT05206890
Treatments Being Tested
Fluzoparib has been approved for the first-line maintenance treatment of ad...
Status
Recruiting
Location
Tongji Hospital
Start Date
2025-05-27
Trial ID
NCT06954584
Treatments Being Tested
This study is a randomized, open-label, multi-cohort, multicenter clinical ...
Status
Recruiting
Location
Qilu Hospital of Shandong University
Start Date
2024-11-27
Trial ID
NCT06735326
Treatments Being Tested
Patients with salivary gland carcinoma were divided into groups according t...
Status
Recruiting
Location
Fei Ma
Start Date
2023-08-15
Trial ID
NCT06145308
Treatments Being Tested
This is a multicenter, randomized, open-label, 2-arm Phase 2 study to evalu...
Status
Completed
Location
Zhejiang Cancer Hospital
Start Date
2020-10-16
Trial ID
NCT04517357
Treatments Being Tested